机译:纤溶酶原激活物抑制剂-1预测慢性艾滋病毒感染中全身胰岛素敏感性的阴性改变
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
Division of Biostatistics Department of Preventive Medicine Keck School of Medicine of USC Los;
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
Blood Systems Research Institute San Francisco California.;
Blood Systems Research Institute San Francisco California.;
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
Department of Medicine Hawaii Center for AIDS University of Hawaii John A. Burns School of;
plasminogen activator inhibitor-1; insulin sensitivity; chronic HIV infection;
机译:纤溶酶原激活物抑制剂-1预测慢性艾滋病毒感染中全身胰岛素敏感性的阴性改变
机译:尿激酶型纤溶酶原激活物,纤溶酶原激活物抑制剂-1和尿激酶型纤溶酶原激活物受体的乳头抽吸液表达可预测乳腺癌的诊断和晚期疾病。
机译:纤溶酶原激活物抑制剂1预测肝脂肪变性的数量,与胰岛素抵抗和体重无关
机译:血液原激活剂抑制剂-1基因中缺乏4g / 5g多态性的关联卒中
机译:纤溶酶原激活剂抑制剂-1(PAI-1)在内皮衰老和心血管老化中的作用
机译:纤溶酶原激活物抑制剂1预测慢性HIV感染的全身胰岛素敏感性的负性变化。
机译:胰岛素样生长因子结合蛋白5通过与组织纤溶酶原激活物相互作用而激活纤溶酶原,而与纤溶酶原激活物抑制剂-1,胰岛素样生长因子-I或肝素的结合能力无关